SouthernWorldwide.com – The Federal Trade Commission (FTC) has initiated a probe into the World Professional Association for Transgender Health (WPATH), an organization widely recognized as a leader in transgender medical treatment. The FTC alleges that WPATH developed influential treatment guidelines for minors based on evidence that its own leaders privately admitted was limited and uncertain.
The complaint, filed in a Texas federal court by the FTC and the attorneys general of Alaska, Iowa, Nebraska, and Texas, specifically accuses WPATH of creating and promoting guidance that healthcare providers have relied upon for recommending puberty blockers, cross-sex hormones, and sex-change procedures for minors.
This legal action could significantly impact the medical guidance that has shaped transgender treatment for thousands of children, potentially determining whether these protocols are founded on robust evidence or agenda-driven speculation.
FTC Chairman Andrew Ferguson emphasized that the lawsuit is a consumer-protection case focused on ensuring families receive complete and truthful information regarding the risks and benefits associated with these treatments.
WASHINGTON POST ADMITS SCIENCE BEHIND PUBERTY BLOCKERS AND HORMONES FOR MINORS NOT CLEAR
“Children, but especially their parents, must have complete and truthful information when making decisions to purchase medical services,” Ferguson stated. “For decades, the FTC has taken action against entities that make deceptive and unsubstantiated health-related claims.”
Central to the lawsuit are allegations that WPATH publicly presented its Standards of Care as evidence-based and supported by expert consensus, while some of its leaders privately acknowledged the limitations of the existing evidence.
The complaint references a 2023 strategy memo from Dr. Eli Coleman, lead author of the Standards of Care 8th edition, which stated, “all of us are painfully aware that there are many gaps in research to back up our recommendations.”
ESSAY EXPOSES CRUMBLING MEDICAL CONSENSUS ON YOUTH GENDER SURGERY
Additionally, the complaint cites comments from Dr. Amy Tishelman, lead author of WPATH’s chapter on children, who acknowledged in an NPR interview that there was no established “research basis” for determining the best assessments or treatments for “transgender youth.”
Federal regulators further allege that WPATH removed age minimums from its 2022 Standards of Care for procedures like breast removal surgeries without scientific justification. Internal discussions cited in the complaint reveal that some WPATH leaders struggled to identify evidence-based reasons supporting these changes.
Kurt Miceli, chief medical officer for Do No Harm, a medical ethics advocacy organization, stated that these allegations raise serious questions about the development of WPATH’s guidelines.
PLASTIC SURGEON CITES ‘EMOTIONAL BLACKMAIL,’ POOR EVIDENCE IN WARNING AGAINST YOUTH GENDER SURGERIES
“The conflicts of interest that are within the standards of care are significant, and again, not brought to light, and this is part of that deception, and the concern that WPATH has sort of stated that the science is there behind pediatric medical transition when it is not,” Miceli commented.
Federal regulators also allege that many of the clinicians and surgeons involved in drafting WPATH’s guidelines had financial and professional interests tied to the treatments being recommended.
“What WPATH did was stack the deck with folks who had a financial invested interest in promoting pediatric medical transition, and subsequently you get guidelines that push hormones, puberty blockers, and surgeries,” Miceli added.
GENDER DYSPHORIA TREATMENTS POSE ‘SIGNIFICANT RISKS’ TO KIDS AND TEENS, HHS REPORT REVEALS
The lawsuit contends that WPATH’s influence extends beyond its membership, with its Standards of Care being widely cited across the medical field, shaping treatment protocols, insurance coverage decisions, and professional guidance throughout the United States.
WPATH is a co-sponsoring organization of the Endocrine Society’s widely used clinical practice guideline on gender dysphoria and gender incongruence. The American Academy of Child and Adolescent Psychiatry identifies WPATH and Endocrine Society guidance as the two most prominent clinical guidelines utilized by providers caring for youth with gender dysphoria.
Among the most critical allegations are claims that WPATH promoted pediatric transition procedures as “lifesaving” despite insufficient evidence to support that such interventions reduce suicide risk.
PROGRESSIVES TRAPPED IN ‘MISINFORMATION BUBBLE’ ABOUT TRANSGENDER YOUTH TREATMENTS, ATLANTIC WRITER ADMITS
The complaint cites instances where parents were allegedly presented with the choice, “Would you rather have a live daughter or a dead son?” when considering treatment options for their children.
“When WPATH says that these are life-saving interventions, and then we hear physicians tell parents, ‘Would you rather have a dead son or a living daughter?’, and we hear that line repeated, which again is not supported by evidence by any means whatsoever,” Miceli explained.
CHLOE COLE REVEALS INTENSE PRESSURE TO TRANSITION AS A MINOR, PARENTS WERE TOLD SHE’D ‘PROBABLY DIE’
The complaint further alleges that some minors who underwent medical transition experienced lasting complications, including chronic pain, sexual dysfunction, urinary incontinence, fertility concerns, nerve damage, and ongoing psychological distress.
WPATH has rejected these allegations, characterizing the lawsuit as politically motivated and legally unsound.
“This is the second time this year the Trump Administration has abused the authority of its agencies to interfere with Americans’ rights to seek and obtain the healthcare that should be decided between a patient and their physician,” the organization stated.
PRISHA MOSLEY: DOCTORS TOOK MY BODY APART FOR GENDER ‘CARE.’ NOW THEY ADMIT IT WAS WRONG
“For more than 50 years, WPATH has been committed to developing guidelines informed by established scientific standards, expert consensus, and patient centered values.”
Miceli suggested that the lawsuit should prompt a comprehensive review by other medical organizations that have relied on WPATH’s guidance.
“We need the American Medical Association, the Endocrine Society, the American Academy of Pediatrics, the American Psychiatric Association—the list goes on—we need them to look at the evidence as well, and they need to do that immediately,” he urged.
“The standards of care is terribly flawed, and again it has done considerable harm as a result,” Miceli concluded.
